2013 Spring ADRC Meeting

Note: Following are links to available presentations from the meeting. The full agendas can be found here.

Administrators Meeting

NIA/NIH Program Officers: General Remarks and Q&A: Nina Silverberg, PhD; Assistant Director, ADRC Program, NIA
NATIONAL Alzheimer's PROJECT ACT (NAPA): Update on National Plan to Address Alzheimer's Disease: Q&A — based on questions presubmitted by ADRC Administrators: Ronald C. Petersen, MD, PhD; Director, Mayo Clinic
COMPETING RENEWALS AND ELECTRONIC FORM SUBMISSION: Planning for the ADRC competing renewal and ASSIST online submission: The long, winding, and bumpy road: Dana M. Swenson-Dravis, MA; Administrator, Mayo Clinic; Mary Sundsmo, MBA; Administrator, University of California, San Diego
THE ROLE OF A RESEARCH ADMINISTRATOR: Perspectives on how we do more with less: money, meetings, and missions; MODERATOR: Jayne LaGrande, MBA; Administrator, University of California, Davis

Entering the new era of Alzheimer's disease prevention research: Eric Reiman, MD; Director, Arizona ADRC
Traumatic brain injury and dementia: What do we know? What should we do?: Elaine Peskind, MD; Associate Director, University of Washington
Lessons from the 68%: The aging female brain: Roberta Brinton, PhD; R. Pete Vanderveen Chair in Therapeutic Discovery and Development; Professor of Pharmacology and Pharmaceutical Sciences, Biomedical Engineering and Neurology; Director, Center for Scientific Translation USC Clinical and Translational Science Institute, University of Southern California

NIA update: Creighton Phelps, PhD; Chief, Dementias of Aging Branch; Director, Alzheimer's Disease Research Centers Program, NIA
NACC update: Walter A. Kukull, PhD; Director, National Alzheimer's Coordinating Center
NCRAD update: Tatiana Foroud, PhD; PI, National Cell Repository for Alzheimer's Disease
ADGC GWAS update: Gerard D. Schellenberg, PhD; PI, Alzheimer's Disease Genetics Consortium
Clinical Task Force update: John C. Morris, MD; Chair, Clinical Task Force
Update on the National Alzheimer's Project Act (NAPA): Ronald C. Petersen, MD, PhD; Director, Mayo Clinic

Overview of conceptual models of reserve: Yaakov Stern, PhD; Associate Director, Columbia University
Decomposition of episodic memory: Bruce Reed, PhD; Associate Director, University of California, Davis
Animal models of neuroplasticity: Carl Cotman, PhD; Associated Director, University of California, Irvine

Update on UDS3: Sandra Weintraub, PhD; Clinical Core Leader, Northwestern University
FTLD Module update: David Knopman, MD; Chair, ADRC Clinical Core Steering Committee
Cerebrospinal fluid studies — Results of Center survey: John Morris, MD; Director, Washington University in St. Louis